Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotics as a Promising Adjunct: Improving Fatigue, Quality of Life, Disability, Mood and Inflammatory Markers in Egyptian Relapsing-Remitting Multiple Sclerosis

NCT07346924 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotics as a Promising Adjunct: Improving Fatigue, Quality of Life, Disability, Mood and Inflammatory Markers in Egyptian Relapsing-Remitting Multiple Sclerosis
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2024
Completion date
March 1, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms) relapsing remitting